Symphony Health data reported by Bloomberg shows Novo Nordisk's oral Wegovy climbing again in week 42, up from 208,304 the week before.
Recap by typeshit. Post by Investseekers on X.
Tara Wider has spent about five years posting on holistic beauty and women's wellness, building a following of women her age on social media.
Brown says diet and exercise still matter, but argues that shaming people for treating obesity with medication has never made anyone healthier.
A short share on growing GLP-1 use in the US, with no figures or sources attached. Thin on detail beyond the headline itself.
A new survey covered by Chain Store Age tracks how GLP-1 users are shifting their food spending from restaurants toward grocery stores.
The updated kit adds an aisle-by-aisle nutrition guide from ShopRite's dietitian plus brand samples, free with a first GLP-1 fill while supplies last.
Lilly's triple agonist outperformed semaglutide on both weight and blood sugar in people with type 2 diabetes, per Medscape's report on the head-to-head data.
Loading…